Cost of Severe Chronic Obstructive Pulmonary Disease Exacerbations in a High Burden Region in North India

Background: Data on costs of acute exacerbations of COPD (AECOPD) in low-income countries are sparse. We conducted a prospective survey to assess direct and indirect costs of severe AECOPD in a tertiary care setting in a high prevalence area of North India. Methods: We conducted face-to-face surveys...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Parvaiz A. Koul, Aqsa Amin Nowshehr, Umar H. Khan, Rafi A. Jan, S. U. Shah
Formato: article
Lenguaje:EN
Publicado: Ubiquity Press 2019
Materias:
Acceso en línea:https://doaj.org/article/82110b9d5ee84166a3a981126e83ae04
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:82110b9d5ee84166a3a981126e83ae04
record_format dspace
spelling oai:doaj.org-article:82110b9d5ee84166a3a981126e83ae042021-12-02T02:17:15ZCost of Severe Chronic Obstructive Pulmonary Disease Exacerbations in a High Burden Region in North India2214-999610.5334/aogh.2423https://doaj.org/article/82110b9d5ee84166a3a981126e83ae042019-01-01T00:00:00Zhttps://annalsofglobalhealth.org/articles/2423https://doaj.org/toc/2214-9996Background: Data on costs of acute exacerbations of COPD (AECOPD) in low-income countries are sparse. We conducted a prospective survey to assess direct and indirect costs of severe AECOPD in a tertiary care setting in a high prevalence area of North India. Methods: We conducted face-to-face surveys using a semi-structured questionnaire among a convenience sample of 129 consenting patients admitted with AECOPD. Data were collected on out-of-pocket costs of hospitalization, consultation, medications, diagnostics, transportation, lodging, and missed work days for self and their attendants. Out-of-pocket costs were supplemented with World Health Organization-CHOICE estimates. Missed work-days were valued on per capita national income (Indian Rupees [INR] 68,748, US$1,145.8). Median total cost per exacerbation episode was INR 44,390 (Inter-quartile range [IQR]: INR 33,354–63,642; US$739.8, IQR: 555.9–1060.7). Hospital costs constituted the largest component of the costs (71%) followed by other costs directly borne by the patient himself (29%), medicine costs (14%), transportation charges (2%) and diagnostic tests (3%). Indirect costs to caregivers (median INR 1,544, IQR: INR 0–17,370 INR; US$25.7, IQR: US$0–289.5), calculated as financial loss due to missed work days, accounted for 4% of the total cost. Expenses were covered by family members in all but 11 patients. Conclusions: AECOPD in India are associated with substantial costs and strategies to reduce the burden of disease such as smoking cessation, influenza and pneumococcal vaccination, etc should be aggressively pursued.Parvaiz A. KoulAqsa Amin NowshehrUmar H. KhanRafi A. JanS. U. ShahUbiquity PressarticleInfectious and parasitic diseasesRC109-216Public aspects of medicineRA1-1270ENAnnals of Global Health, Vol 85, Iss 1 (2019)
institution DOAJ
collection DOAJ
language EN
topic Infectious and parasitic diseases
RC109-216
Public aspects of medicine
RA1-1270
spellingShingle Infectious and parasitic diseases
RC109-216
Public aspects of medicine
RA1-1270
Parvaiz A. Koul
Aqsa Amin Nowshehr
Umar H. Khan
Rafi A. Jan
S. U. Shah
Cost of Severe Chronic Obstructive Pulmonary Disease Exacerbations in a High Burden Region in North India
description Background: Data on costs of acute exacerbations of COPD (AECOPD) in low-income countries are sparse. We conducted a prospective survey to assess direct and indirect costs of severe AECOPD in a tertiary care setting in a high prevalence area of North India. Methods: We conducted face-to-face surveys using a semi-structured questionnaire among a convenience sample of 129 consenting patients admitted with AECOPD. Data were collected on out-of-pocket costs of hospitalization, consultation, medications, diagnostics, transportation, lodging, and missed work days for self and their attendants. Out-of-pocket costs were supplemented with World Health Organization-CHOICE estimates. Missed work-days were valued on per capita national income (Indian Rupees [INR] 68,748, US$1,145.8). Median total cost per exacerbation episode was INR 44,390 (Inter-quartile range [IQR]: INR 33,354–63,642; US$739.8, IQR: 555.9–1060.7). Hospital costs constituted the largest component of the costs (71%) followed by other costs directly borne by the patient himself (29%), medicine costs (14%), transportation charges (2%) and diagnostic tests (3%). Indirect costs to caregivers (median INR 1,544, IQR: INR 0–17,370 INR; US$25.7, IQR: US$0–289.5), calculated as financial loss due to missed work days, accounted for 4% of the total cost. Expenses were covered by family members in all but 11 patients. Conclusions: AECOPD in India are associated with substantial costs and strategies to reduce the burden of disease such as smoking cessation, influenza and pneumococcal vaccination, etc should be aggressively pursued.
format article
author Parvaiz A. Koul
Aqsa Amin Nowshehr
Umar H. Khan
Rafi A. Jan
S. U. Shah
author_facet Parvaiz A. Koul
Aqsa Amin Nowshehr
Umar H. Khan
Rafi A. Jan
S. U. Shah
author_sort Parvaiz A. Koul
title Cost of Severe Chronic Obstructive Pulmonary Disease Exacerbations in a High Burden Region in North India
title_short Cost of Severe Chronic Obstructive Pulmonary Disease Exacerbations in a High Burden Region in North India
title_full Cost of Severe Chronic Obstructive Pulmonary Disease Exacerbations in a High Burden Region in North India
title_fullStr Cost of Severe Chronic Obstructive Pulmonary Disease Exacerbations in a High Burden Region in North India
title_full_unstemmed Cost of Severe Chronic Obstructive Pulmonary Disease Exacerbations in a High Burden Region in North India
title_sort cost of severe chronic obstructive pulmonary disease exacerbations in a high burden region in north india
publisher Ubiquity Press
publishDate 2019
url https://doaj.org/article/82110b9d5ee84166a3a981126e83ae04
work_keys_str_mv AT parvaizakoul costofseverechronicobstructivepulmonarydiseaseexacerbationsinahighburdenregioninnorthindia
AT aqsaaminnowshehr costofseverechronicobstructivepulmonarydiseaseexacerbationsinahighburdenregioninnorthindia
AT umarhkhan costofseverechronicobstructivepulmonarydiseaseexacerbationsinahighburdenregioninnorthindia
AT rafiajan costofseverechronicobstructivepulmonarydiseaseexacerbationsinahighburdenregioninnorthindia
AT sushah costofseverechronicobstructivepulmonarydiseaseexacerbationsinahighburdenregioninnorthindia
_version_ 1718402605766410240